Roche’s vision-loss drug Vabysmo gets EU nod
[ad_1] Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in the European Union after successful phase-3 study data. Vabysmo (faricimab) is a treatment for age-related…
[ad_1] Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in the European Union after successful phase-3 study data. Vabysmo (faricimab) is a treatment for age-related…